Binge Drinking Triples Liver Fibrosis Risk

A new study suggests that even infrequent binge drinking can significantly elevate the risk of serious liver conditions. Researchers found that a single episode of heavy drinking per month was associated with a threefold increase in advanced liver fibrosis among individuals with metabolic liver disease. This advanced stage is characterized by substantial scar tissue accumulation resulting from long-term inflammation.

The research analyzed data from over 8,000 adults, focusing on those with metabolic dysfunction-associated steatotic liver disease (MASLD), a common fatty liver condition linked to obesity and metabolic disorders. The findings indicate that the pattern of alcohol consumption is a crucial factor, rather than simply the average weekly intake.

Occasional heavy drinking, defined as four or more drinks for women and five or more for men in a single session at least once a month, demonstrated a higher risk for advanced liver fibrosis compared to spreading consumption over longer periods. This pattern was more prevalent among younger adults and men, with increased drinks per session correlating with greater liver scarring.

Experts emphasize that consuming alcohol within a weekly 'quota' by abstaining on weekdays and drinking heavily on weekends is not a safe practice. The study, published in Clinical Gastroenterology and Hepatology, acknowledges limitations such as its observational nature and reliance on self-reported data. The findings primarily apply to individuals with MASLD and call for further research into preventative strategies for liver disease.